Related Experiment Video
Updated: Sep 14, 2025

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
The intestine and cardiovascular disease
Samuel C Delk1,2, Srinivasa T Reddy1,2,3, Alan M Fogelman1
1Division of Cardiology, Department of Medicine.
The gut microbiome and tryptophan metabolism significantly impact cardiovascular disease risk. Altering the 5-hydroxytryptamine (serotonin) pathway in the intestine can reduce atherosclerosis progression.
Area of Science:
- Gastroenterology
- Cardiology
- Microbiology
Background:
- Cardiovascular disease (CVD) pathogenesis is increasingly linked to intestinal health.
- The gut microbiota and its metabolites play a crucial role in systemic inflammation and metabolic processes.
Purpose of the Study:
- To review recent literature on the intestine's role in CVD.
- To investigate the impact of intestinal tryptophan metabolism and microbiota on atherosclerosis.
Main Methods:
- Analysis of fecal microbiota and lipopolysaccharide (LPS) levels in relation to cardiovascular events.
- Utilizing Ldlr-/- mice fed a high-fat, high-cholesterol diet (HFD+HCD) to model atherosclerosis.
- Investigating the effects of indoleamine-2,3-dioxygenase 1 (IDO1) deficiency and 5-hydroxytryptamine (5-HT) pathway inhibition in mice.
Main Results:
- Fecal microbiota and LPS patterns predicted future cardiovascular events.
- High-fat diets increased intestinal IDO1 activity, reducing beneficial metabolites like butyrate and serotonin.
- IDO1 deficiency or 5-HT pathway inhibition in mice improved gut barrier function, reduced inflammation, and decreased atherosclerosis.
Conclusions:
- Intestinal tryptophan metabolism and microbiota-derived products are critical in atherosclerosis development.
- Targeting the intestinal 5-HT pathway offers a potential therapeutic strategy for CVD.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Supply to the Digestive System
Blood Supply to the Digestive System: The splanchnic circulation involves three main arteries: the celiac artery (also known as the celiac trunk) and the superior and inferior mesenteric...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

